- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04485520
Efficacy of the Extract of Carica Papaya as an Inhibitor of Streptococcus Mutans
August 17, 2021 updated by: Julieta María Méndez Romero
Efficacy of the Extract of Carica Papaya as an Inhibitor of Streptococcus Mutans in Students of the Faculty of Dentistry in the Year 2018
Papaya has effects on oral pathogenic microorganisms, it also has anticoagulant quality, amebicidal action, antimicrobial, bacteriostatic and antifungal activity on different bacteria, especially on Streptococcus mutans, this can be exploited in the dental area.
The objective of the study was to determine the efficacy of Carica Papaya peel extract (suckling) as an inhibitor of Streptococcus Mutans in students of the dental faculty of the National University of Caaguazú in 2018.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Specific objectives
- To determine the inhibition of the extract of the peel of Carica Papaya (baby) at 3% on Streptococcus Mutans by age and sex grouping.
- To quantify the inhibition of the extract of the peel of Carica Papaya (baby) at 3% on the growth of Streptococcus Mutans before, at 10 minutes and 8 days of use in the experimental group.
- Quantify the inhibition of 0.12% Chlorhexidine Gluconate on the growth of Streptococcus Mutans before, after 10 minutes and 8 days of use in the control group.
- Compare the count of Colony Forming Units (CFU) between both groups.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
International
-
Coronel Oviedo, International, Paraguay, 595
- Facultad de Odontología Universidad Nacional de Caaguazú
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participants that signed the informed consent
Exclusion Criteria:
- allergic to carica papaya
- ongoing medical or dental treatment that could interfere with the results.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Carica Papaya extract
Carica Papaya at 3%
|
Each application was 10 ml.
applied for 1 minute, once a day for 8 days
|
Active Comparator: Chlorhexidine
0.12% chlorhexidine mouthwash formulation (commercially available)
|
Each application was 10 ml.
applied for 1 minute, once a day for 8 days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Colony Forming units (Stage 1)
Time Frame: thorough study completion, an average of 24 hours
|
Before Intervention
|
thorough study completion, an average of 24 hours
|
Number of Colony Forming units (Stage 2)
Time Frame: 10 minutes after mouthwash use
|
After Intervention
|
10 minutes after mouthwash use
|
Number of Colony Forming units (Stage 3)
Time Frame: 8 days after mouthwash use
|
After Intervention
|
8 days after mouthwash use
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Diego Céspedes, Facultad de Odontología, Universidad nacional de Caaguazu
- Study Director: Ulises A Villasanti Torales, Facultad de Odontología, Universidad nacional de Caaguazu
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 21, 2017
Primary Completion (Actual)
October 21, 2017
Study Completion (Actual)
October 21, 2017
Study Registration Dates
First Submitted
July 21, 2020
First Submitted That Met QC Criteria
July 23, 2020
First Posted (Actual)
July 24, 2020
Study Record Updates
Last Update Posted (Actual)
August 18, 2021
Last Update Submitted That Met QC Criteria
August 17, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00140
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
By email
IPD Sharing Time Frame
From the time the protocol is available in clinical trials.gov
and with no limit of time
IPD Sharing Access Criteria
Researchers that want to know about the study and use the protocol
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Plaque
-
Azienda Ospedaliera Città della Salute e della...Recruiting
-
Colgate PalmoliveCompleted
-
Church & Dwight Company, Inc.Completed
-
Damascus UniversityCompletedPlaque, DentalSyrian Arab Republic
-
Church & Dwight Company, Inc.Completed
-
Church & Dwight Company, Inc.CompletedPlaque, DentalUnited States
-
Colgate PalmoliveCompleted
-
Multan Medical And Dental CollegeUnknown
-
Marmara UniversityCompletedPlaque, DentalTurkey
-
Heba sabbaghCompleted
Clinical Trials on CARICA PAPAYA MOUTHWASH
-
Institute of Liver and Biliary Sciences, IndiaRecruitingThrombocytopeniaIndia
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...Institute of Technology Transfer and Innovation (ITTI)Completed
-
Vedic Lifesciences Pvt. Ltd.Recruiting
-
Isfahan University of Medical SciencesCompletedIrritable Bowel Syndrome Predominant ConstipationIran, Islamic Republic of
-
University of FloridaOsato Research InstituteCompleted
-
Government Dental College and Research Institute...Himalaya Drug Company Research and Development, Makali, Bangalore, IndiaCompletedDentinal Hypersensitivity
-
Chonbuk National University HospitalCompletedFunctional ConstipationKorea, Republic of
-
Chonbuk National University HospitalCompletedFunctional ConstipationKorea, Republic of
-
Rennes University HospitalNot yet recruiting
-
University of Santiago de CompostelaLacer, S.A.CompletedHealthy | Dental PlaqueSpain